These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29080909)

  • 1. Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications.
    Legrand M; Ludes PO; Massy Z; Rossignol P; Parenica J; Park JJ; Ishihara S; AlHabib KF; Maggioni A; Miró Ò; Sato N; Cohen-Solal A; Fairman E; Lassus J; Harjola VP; Mueller C; Peacock FW; Choi DJ; Plaisance P; Spinar J; Kosiborod M; Mebazaa A; Gayat E;
    Clin Res Cardiol; 2018 Mar; 107(3):214-221. PubMed ID: 29080909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blockers do not protect against cardiac toxicity of hyperkalemia : Response to the article by Legrand et al. 'Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications' [1].
    de Tymowski C; Atchade E; Montravers P; Provenchère S
    Clin Res Cardiol; 2018 Sep; 107(9):868-869. PubMed ID: 29532156
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK.
    Linde C; Qin L; Bakhai A; Furuland H; Evans M; Ayoubkhani D; Palaka E; Bennett H; McEwan P
    ESC Heart Fail; 2019 Apr; 6(2):280-290. PubMed ID: 30629342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist.
    Vardeny O; Claggett B; Anand I; Rossignol P; Desai AS; Zannad F; Pitt B; Solomon SD;
    Circ Heart Fail; 2014 Jul; 7(4):573-9. PubMed ID: 24812304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis.
    Salah K; Pinto YM; Eurlings LW; Metra M; Stienen S; Lombardi C; Tijssen JG; Kok WE
    Am Heart J; 2015 Sep; 170(3):531-42.e1. PubMed ID: 26385037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study.
    Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Kimura H; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
    Clin Exp Nephrol; 2021 Apr; 25(4):410-417. PubMed ID: 33411113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study.
    Chen Y; Chang AR; McAdams DeMarco MA; Inker LA; Matsushita K; Ballew SH; Coresh J; Grams ME
    Mayo Clin Proc; 2016 Oct; 91(10):1403-1412. PubMed ID: 27499535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of serum potassium concentration on mortality after liver transplantation: a cohort multicenter study.
    Dawwas MF; Lewsey JD; Watson CJ; Gimson AE;
    Transplantation; 2009 Aug; 88(3):402-10. PubMed ID: 19667945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Potassium and Cardiovascular Events in Heart Failure With Preserved Left Ventricular Ejection Fraction Patients.
    Nishihara T; Tokitsu T; Sueta D; Takae M; Oike F; Fujisue K; Usuku H; Takashio S; Hanatani S; Kanazawa H; Arima Y; Sakamoto K; Izumiya Y; Yamabe H; Kaikita K; Yamamoto E; Tsujita K
    Am J Hypertens; 2018 Sep; 31(10):1098-1105. PubMed ID: 29985986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association between serum potassium levels and all-cause mortality in patients with acute heart failure].
    Huang BP; Zhou Q; Zhao L; Zhao XM; Zhai M; Tian PC; Liang L; Huang LY; Feng JY; Zhang YH; Huang Y; Zhang J
    Zhonghua Yi Xue Za Zhi; 2023 Mar; 103(10):727-732. PubMed ID: 36889685
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical outcomes by serum potassium levels for patients hospitalized for heart failure: Secondary analysis of data from the China National Heart Failure Registry.
    Zhou J; Jin X; Zhou J; Xu Y; Cui X; Fu M; Hu K; Ge J;
    Clin Cardiol; 2023 Nov; 46(11):1345-1352. PubMed ID: 37577821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of dyskalemia at admission and early dyskalemia correction on survival and cardiac events of critically ill patients.
    Bouadma L; Mankikian S; Darmon M; Argaud L; Vinclair C; Siami S; Garrouste-Orgeas M; Papazian L; Cohen Y; Marcotte G; Styfalova L; Reignier J; Lautrette A; Schwebel C; Timsit JF;
    Crit Care; 2019 Dec; 23(1):415. PubMed ID: 31856891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes.
    Collins AJ; Pitt B; Reaven N; Funk S; McGaughey K; Wilson D; Bushinsky DA
    Am J Nephrol; 2017; 46(3):213-221. PubMed ID: 28866674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyskalemia, its patterns, and prognosis among patients with incident heart failure: A nationwide study of US veterans.
    Matsushita K; Sang Y; Yang C; Ballew SH; Grams ME; Coresh J; Molnar MZ
    PLoS One; 2019; 14(8):e0219899. PubMed ID: 31393910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of serum potassium levels with mortality in chronic heart failure patients.
    Aldahl M; Jensen AC; Davidsen L; Eriksen MA; Møller Hansen S; Nielsen BJ; Krogager ML; Køber L; Torp-Pedersen C; Søgaard P
    Eur Heart J; 2017 Oct; 38(38):2890-2896. PubMed ID: 29019614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial and Ethnic Differences in Mortality Associated with Serum Potassium in Incident Peritoneal Dialysis Patients.
    Eriguchi R; Obi Y; Soohoo M; Rhee CM; Kovesdy CP; Kalantar-Zadeh K; Streja E
    Am J Nephrol; 2019; 50(5):361-369. PubMed ID: 31522173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction (from the EVEREST trial).
    Khan SS; Campia U; Chioncel O; Zannad F; Rossignol P; Maggioni AP; Swedberg K; Konstam MA; Senni M; Nodari S; Vaduganathan M; Subacius H; Butler J; Gheorghiade M;
    Am J Cardiol; 2015 Mar; 115(6):790-6. PubMed ID: 25728846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperkalemia is Associated with Increased 30-Day Mortality in Hip Fracture Patients.
    Norring-Agerskov D; Madsen CM; Abrahamsen B; Riis T; Pedersen OB; Jørgensen NR; Bathum L; Lauritzen JB; Jørgensen HL
    Calcif Tissue Int; 2017 Jul; 101(1):9-16. PubMed ID: 28213863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.